98 related articles for article (PubMed ID: 8442669)
1. Morphometric analysis of benign and malignant adrenal pheochromocytomas.
Hoffman K; Gil J; Barba J; Liu Z; Pertsemlidis D; Kaneko M; Unger P
Arch Pathol Lab Med; 1993 Mar; 117(3):244-7. PubMed ID: 8442669
[TBL] [Abstract][Full Text] [Related]
2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
3. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
[TBL] [Abstract][Full Text] [Related]
4. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
5. [Malignant pheochromocytoma. A case report and comments on a rare pathology].
Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S
Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of telomerase activity in malignant pheochromocytoma.
Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
[TBL] [Abstract][Full Text] [Related]
7. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
[TBL] [Abstract][Full Text] [Related]
8. Development of differential diagnosis for benign and malignant pheochromocytomas.
Gao B; Kong F; Xu Z
Int J Urol; 2008 Sep; 15(9):771-7. PubMed ID: 18651863
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
Nagura S; Katoh R; Kawaoi A; Kobayashi M; Obara T; Omata K
Mod Pathol; 1999 Dec; 12(12):1107-11. PubMed ID: 10619262
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of pheochromocytomas.
Lloyd RV; Shapiro B; Sisson JC; Kalff V; Thompson NW; Beierwaltes WA
Arch Pathol Lab Med; 1984 Jul; 108(7):541-4. PubMed ID: 6203498
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
[TBL] [Abstract][Full Text] [Related]
12. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
[TBL] [Abstract][Full Text] [Related]
13. Malignancy in pheochromocytomas.
Salmenkivi K; Heikkilä P; Haglund C; Arola J
APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms.
Mlika M; Kourda N; Zorgati MM; Bahri S; Ben Ammar S; Zermani R
Tunis Med; 2013 Mar; 91(3):209-15. PubMed ID: 23588637
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.
Gao B; Meng F; Bian W; Chen J; Zhao H; Ma G; Shi B; Zhang J; Liu Y; Xu Z
Urology; 2006 Aug; 68(2):282-6. PubMed ID: 16904437
[TBL] [Abstract][Full Text] [Related]
17. Nuclear DNA content, proliferation index and nuclear size determination in normal and tumoral adrenal tissues, pheochromocytomas and metastases.
Remmelink M; Salmon I; Pasteels JL; Ardichvili D; Kiss R
Acta Cytol; 1995; 39(3):416-22. PubMed ID: 7762326
[TBL] [Abstract][Full Text] [Related]
18. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.
Unger P; Hoffman K; Pertsemlidis D; Thung S; Wolfe D; Kaneko M
Arch Pathol Lab Med; 1991 May; 115(5):484-7. PubMed ID: 1673596
[TBL] [Abstract][Full Text] [Related]
19. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
[TBL] [Abstract][Full Text] [Related]
20. [Comparative secretory profiles of benign and malignant pheochromocytomas].
Proye C; Racadot-Leroy N; Vix M; Vermesse B; Carnaille B
Ann Chir; 1994; 48(5):430-4. PubMed ID: 7810975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
